Showing results (31-40 of 217) with videos related to
Sort By:
Pageof 22
American Journal of Clinical Pathology|June 6, 2002
HER2/neu amplification in breast cancer: stratification by tumor type and gradeElise R Hoff, Raymond R Tubbs, Jonathan L Myles, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|November 18, 2011
HER2 testing in gastric and gastroesophageal junction cancers: a new therapeutic target and diagnostic challengeDavid G Hicks, Christa Whitney-MillerBiotechnic & Histochemistry : Official Publication of the Biological Stain Commission|September 11, 2024
Optimized biomarker evaluation and molecular testing in the era of breast cancer precision medicineDavid G Hicks, Bradley M TurnerDiagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|February 27, 2003
Automated colorimetric in situ hybridization (CISH) detection of immunoglobulin (Ig) light chain mRNA expression in plasma cell (PC) dyscrasias and non-Hodgkin lymphomaRose C Beck, Raymond R Tubbs, Mohamad Hussein, et al.The American Journal of Surgical Pathology|October 8, 2009
Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcomaAmanda Jagdis, Brian P Rubin, Raymond R Tubbs, et al.American Journal of Clinical Pathology|April 22, 2006
Immunohistochemical analysis identifies two cyclin D1+ subsets of plasma cell myeloma, each associated with favorable survivalJames R Cook, Eric D Hsi, Sarah Worley, et al.The Breast Journal|February 27, 2007
The expression of the cytoskeletal focal adhesion protein paxillin in breast cancer correlates with HER2 overexpression and may help predict response to chemotherapy: a retrospective immunohistochemical studySarah M Short, Brian J Yoder, Shannon M Tarr, et al.Journal of Cutaneous Pathology|November 30, 2011
FISH for MYC amplification and anti-MYC immunohistochemistry: useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferationsAnthony P Fernandez, Yang Sun, Raymond R Tubbs, et al.Archives of Pathology & Laboratory Medicine|September 30, 2016
Automated Bright-Field Dual-Color In Situ Hybridization for MDM2: Interobserver Reproducibility and Correlation With Fluorescence In Situ Hybridization in a Series of Soft Tissue ConsultsGloria Zhang, Christopher P Lanigan, John R Goldblum, et al.Journal of the National Cancer Institute. Monographs|June 16, 2011
Breast cancer predictive factor testing: the challenges and importance of standardizing tissue handlingDavid G Hicks, LeeAnn Kushner, Kristin McCarthyPageof 22